NCT00005843View on ClinicalTrials.gov

R115777 in Treating Patients Who Have Metastatic Pancreatic Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

September 30, 2004

Conditions
Pancreatic Cancer
Interventions
DRUG

tipifarnib

Trial Locations (2)

19111

Fox Chase Cancer Center, Philadelphia

77030-4009

University of Texas - MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00005843 - R115777 in Treating Patients Who Have Metastatic Pancreatic Cancer | Biotech Hunter | Biotech Hunter